New Results
Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes: an overview of the data from the epidemiological studies within the IMI DIRECT Consortium
View ORCID ProfileRobert W. Koivula, Ian M. Forgie, Azra Kurbasic, View ORCID ProfileAna Viñuela, Alison Heggie, Giuseppe N. Giordano, View ORCID ProfileTue H. Hansen, Michelle Hudson, Anitra Koopman, Femke Rutters, Maritta Siloaho, Kristine H. Allin, Søren Brage, Caroline A. Brorsson, Adem Y. Dawed, Federico De Masi, Christopher J. Groves, Tarja Kokkola, View ORCID ProfileAnubha Mahajan, Mandy H. Perry, Simone P. Rauh, Martin Ridderstråle, Harriet J. A. Teare, Louise Thomas, Andrea Tura, Henrik Vestergaard, View ORCID ProfileTom White, Jerzy Adamski, Jimmy Bell, Søren Brunak, Jacqueline Dekker, Emmanouil T. Dermitzakis, Philippe Froguel, Gary Frost, Ramneek Gupta, Torben Hansen, Andrew Hattersley, Bernd Jablonka, Markku Laakso, Timothy J. McDonald, Oluf Pedersen, View ORCID ProfileJochen M. Schwenk, Imre Pavo, Andrea Mari, View ORCID ProfileMark I. McCarthy, Hartmut Ruetten, Mark Walker, Ewan Pearson, View ORCID ProfilePaul W. Franks, for the IMIDIRECT Consortium
doi: https://doi.org/10.1101/300244
Robert W. Koivula
1Department of Clinical Sciences, Genetic and Molecular Epidemiology Unit, Skåne University Hospital Malmö, Lund University, Malmö, Sweden
2Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom
Ian M. Forgie
3Molecular and Clinical Medicine, School of Medicine, University of Dundee, Ninewells Hospital, Dundee, United Kingdom
Azra Kurbasic
1Department of Clinical Sciences, Genetic and Molecular Epidemiology Unit, Skåne University Hospital Malmö, Lund University, Malmö, Sweden
Ana Viñuela
4Department of Genetic Medicine and Development, University of Geneva Medical School, Geneva, Switzerland
5Institute of Genetics and Genomics in Geneva (iGE3), University of Geneva, Geneva, Switzerland
6Swiss Institute of Bioinformatics, Geneva, Switzerland
Alison Heggie
7Institute of Cellular Medicine (Diabetes), Newcastle University, Newcastle upon Tyne, United Kingdom
Giuseppe N. Giordano
1Department of Clinical Sciences, Genetic and Molecular Epidemiology Unit, Skåne University Hospital Malmö, Lund University, Malmö, Sweden
Tue H. Hansen
8The Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Science, University of Copenhagen
Michelle Hudson
9NIHR Exeter Clinical Research Facility, University of Exeter Medical School, Exeter, UK
Anitra Koopman
10Department of Epidemiology and Biostatistics, Amsterdam Public Health Research Institute, VU University Medical Center, Amsterdam, the Netherlands
Femke Rutters
10Department of Epidemiology and Biostatistics, Amsterdam Public Health Research Institute, VU University Medical Center, Amsterdam, the Netherlands
Maritta Siloaho
11Department of Medicine, University of Eastern Finland and Kuopio University Hospital, Finland
Kristine H. Allin
8The Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Science, University of Copenhagen
12Department of Clinical Epidemiology, Bispebjerg and Frederiksberg Hospital, the Capital Region, Copenhagen, Denmark
Søren Brage
13Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark
Caroline A. Brorsson
14Department of Bio and Health Informatics, Technical University of Denmark, Lyngby, Denmark
Adem Y. Dawed
3Molecular and Clinical Medicine, School of Medicine, University of Dundee, Ninewells Hospital, Dundee, United Kingdom
Federico De Masi
14Department of Bio and Health Informatics, Technical University of Denmark, Lyngby, Denmark
Christopher J. Groves
2Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom
Tarja Kokkola
11Department of Medicine, University of Eastern Finland and Kuopio University Hospital, Finland
Anubha Mahajan
15Wellcome Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK
Mandy H. Perry
16NIHR Exeter Clinical Research Facility, University of Exeter Medical School and Royal Devon and Exeter NHS Foundation Trust, Exeter, UK
Simone P. Rauh
10Department of Epidemiology and Biostatistics, Amsterdam Public Health Research Institute, VU University Medical Center, Amsterdam, the Netherlands
Martin Ridderstråle
17Department of Clinical Sciences, Clinical Obesity, Skåne University Hospital Malmö, Lund University, Malmo, Sweden
Harriet J. A. Teare
18HeLEX, Nuffield Department of Population Health, University of Oxford, Old Road Campus, Headington, Oxford, UK
Louise Thomas
19Research Centre for Optimal Health, Department of Life Sciences, University of Westminster, London, U.K
Andrea Tura
20Institute of Neurosciences, National Research Council, Padova, Italy
Henrik Vestergaard
8The Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Science, University of Copenhagen
Tom White
21MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, UK
Jerzy Adamski
22Institute of Epidemiology II, Helmholtz Zentrum Muenchen, German Research Center for Environmental Health (GmbH) Neuherberg, Germany
Jimmy Bell
19Research Centre for Optimal Health, Department of Life Sciences, University of Westminster, London, U.K
Søren Brunak
14Department of Bio and Health Informatics, Technical University of Denmark, Lyngby, Denmark
23The Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark
Jacqueline Dekker
10Department of Epidemiology and Biostatistics, Amsterdam Public Health Research Institute, VU University Medical Center, Amsterdam, the Netherlands
Emmanouil T. Dermitzakis
4Department of Genetic Medicine and Development, University of Geneva Medical School, Geneva, Switzerland
5Institute of Genetics and Genomics in Geneva (iGE3), University of Geneva, Geneva, Switzerland
6Swiss Institute of Bioinformatics, Geneva, Switzerland
Philippe Froguel
24Department of Genomics of Common Disease, School of Public Health, Imperial College London, London, United Kingdom
25CNRS, Pasteur Institute of Lille, University of Lille, Lille, France
Gary Frost
26Nutrition and Dietetics Research Group, Department of Medicine, Division of Diabetes, Endocrinology and Metabolism, Imperial College London, Hammersmith Campus, London W12 0NN, UK
Ramneek Gupta
14Department of Bio and Health Informatics, Technical University of Denmark, Lyngby, Denmark
Torben Hansen
8The Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Science, University of Copenhagen
13Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark
Andrew Hattersley
16NIHR Exeter Clinical Research Facility, University of Exeter Medical School and Royal Devon and Exeter NHS Foundation Trust, Exeter, UK
27Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, UK
Bernd Jablonka
28Sanofi-Aventis Deutschland GmbH, R&D, Frankfurt am Main, Germany
Markku Laakso
11Department of Medicine, University of Eastern Finland and Kuopio University Hospital, Finland
Timothy J. McDonald
16NIHR Exeter Clinical Research Facility, University of Exeter Medical School and Royal Devon and Exeter NHS Foundation Trust, Exeter, UK
Oluf Pedersen
8The Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Science, University of Copenhagen
Jochen M. Schwenk
29Science for Life Laboratory, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH - Royal Institute of Technology, Stockholm, Sweden
Imre Pavo
30Eli Lilly Regional Operations GmbH, Vienna, Austria
Andrea Mari
21MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, UK
Mark I. McCarthy
2Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom
15Wellcome Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK
31NIHR Oxford Biomedical Research Centre, Churchill Hospital, Oxford, UK
Hartmut Ruetten
28Sanofi-Aventis Deutschland GmbH, R&D, Frankfurt am Main, Germany
Mark Walker
7Institute of Cellular Medicine (Diabetes), Newcastle University, Newcastle upon Tyne, United Kingdom
Ewan Pearson
3Molecular and Clinical Medicine, School of Medicine, University of Dundee, Ninewells Hospital, Dundee, United Kingdom
Paul W. Franks
1Department of Clinical Sciences, Genetic and Molecular Epidemiology Unit, Skåne University Hospital Malmö, Lund University, Malmö, Sweden
2Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom
32Department of Nutrition, Harvard School of Public Health, Boston, USA
33Department of Public Health & Clinical Medicine, Section for Medicine, Umeå University Hospital, Umeå, Sweden
Article usage
Posted April 16, 2018.
Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes: an overview of the data from the epidemiological studies within the IMI DIRECT Consortium
Robert W. Koivula, Ian M. Forgie, Azra Kurbasic, Ana Viñuela, Alison Heggie, Giuseppe N. Giordano, Tue H. Hansen, Michelle Hudson, Anitra Koopman, Femke Rutters, Maritta Siloaho, Kristine H. Allin, Søren Brage, Caroline A. Brorsson, Adem Y. Dawed, Federico De Masi, Christopher J. Groves, Tarja Kokkola, Anubha Mahajan, Mandy H. Perry, Simone P. Rauh, Martin Ridderstråle, Harriet J. A. Teare, Louise Thomas, Andrea Tura, Henrik Vestergaard, Tom White, Jerzy Adamski, Jimmy Bell, Søren Brunak, Jacqueline Dekker, Emmanouil T. Dermitzakis, Philippe Froguel, Gary Frost, Ramneek Gupta, Torben Hansen, Andrew Hattersley, Bernd Jablonka, Markku Laakso, Timothy J. McDonald, Oluf Pedersen, Jochen M. Schwenk, Imre Pavo, Andrea Mari, Mark I. McCarthy, Hartmut Ruetten, Mark Walker, Ewan Pearson, Paul W. Franks, for the IMIDIRECT Consortium
bioRxiv 300244; doi: https://doi.org/10.1101/300244
Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes: an overview of the data from the epidemiological studies within the IMI DIRECT Consortium
Robert W. Koivula, Ian M. Forgie, Azra Kurbasic, Ana Viñuela, Alison Heggie, Giuseppe N. Giordano, Tue H. Hansen, Michelle Hudson, Anitra Koopman, Femke Rutters, Maritta Siloaho, Kristine H. Allin, Søren Brage, Caroline A. Brorsson, Adem Y. Dawed, Federico De Masi, Christopher J. Groves, Tarja Kokkola, Anubha Mahajan, Mandy H. Perry, Simone P. Rauh, Martin Ridderstråle, Harriet J. A. Teare, Louise Thomas, Andrea Tura, Henrik Vestergaard, Tom White, Jerzy Adamski, Jimmy Bell, Søren Brunak, Jacqueline Dekker, Emmanouil T. Dermitzakis, Philippe Froguel, Gary Frost, Ramneek Gupta, Torben Hansen, Andrew Hattersley, Bernd Jablonka, Markku Laakso, Timothy J. McDonald, Oluf Pedersen, Jochen M. Schwenk, Imre Pavo, Andrea Mari, Mark I. McCarthy, Hartmut Ruetten, Mark Walker, Ewan Pearson, Paul W. Franks, for the IMIDIRECT Consortium
bioRxiv 300244; doi: https://doi.org/10.1101/300244
Subject Area
Subject Areas
- Biochemistry (11730)
- Bioengineering (8743)
- Bioinformatics (29179)
- Biophysics (14964)
- Cancer Biology (12080)
- Cell Biology (17399)
- Clinical Trials (138)
- Developmental Biology (9417)
- Ecology (14174)
- Epidemiology (2067)
- Evolutionary Biology (18294)
- Genetics (12233)
- Genomics (16791)
- Immunology (11858)
- Microbiology (28051)
- Molecular Biology (11575)
- Neuroscience (60919)
- Paleontology (451)
- Pathology (1870)
- Pharmacology and Toxicology (3238)
- Physiology (4955)
- Plant Biology (10422)
- Synthetic Biology (2881)
- Systems Biology (7338)
- Zoology (1650)